10,023 followers
#Blood&Cancer A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or re… https://t.co/Vh7zERalaK
#Blood&Cancer A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or re… https://t.co/Vh7zERalaK